Moreover, lipocalin 2 modulated by PPARG could be a potential pathway involved in concurrent inflammation and ankylosis in inflammatory bowel diseases and ankylosing spondylitis [44]. The gene discussed is LCN2; the disease is ankylosing spondylitis.